Clinical TrialsSearch results
Number of results: 228
Other
- A prospective Study of Treatment for Renal Anemia on Prognosis in Hemodialysis Patients
- Patients with renal anemia receiving erythropoietin, who have maintained dialysis therapy for over 1 year
- TRAP study office
- 2007-06-01
Other
- A prospective, time-series, multicenter study on the effect of telmisartan on intra-renal RAS in type 2 diabetes.
- Type 2 Diabetes Mellitus
- Kagawa University, Faculty of Medicine
- 2009-04-14
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Other
- A randomized controlled study comparing Anastrozole+TS-1 as postoperative chemotherapy in ER positive metastatic breast cancer
- Breast Cancer
- Department of Breast and Thyroid Surgery, Kawasaki Medical School
- 2007-08-12
Other
- A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.
- Rectal Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-04-01
Other
- A Randomized Multicenter Phase2 Trial of Neoadjuvant Paclitaxel followed by Fluorouracil,Epirubin,and Cyclophosphamide(FEC)with or without Estrogen Deprivation by LH-RH agonist or Aromatase Inhibitor in Breast Cancer larger than 2 cm.
- Breast Cancer
- THE FIRST
- 2007-06-30
Other
- A Randomized Phase II study of Carboplatin and Paclitaxel or Gemcitabine and Vinorelbine in ECOG PS2 patients with advanced non-small cell lung cancer
- ECOG PS2 patients with advanced non-small cell lung cancer
- West Japan Oncology Group
- 2005-08-31
Other
- A Randomized phase II study of docetaxel versus weekly carboplatin and CPT-11 for previously treated Non-Small cell lung cancer
- second line chemotherapy for Non-Small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- A randomized phase II study of FOLFOXIRI plus cetuximab versus FOLFOXIRI plus bevacizumab in metastatic colorectal cancer patients with RAS wild-type tumors
- colorectal cancer
- TSUJI Akihito
- 2019-02-14
Other
- A randomized phase III trial of AP(Doxorubicin+Cisplatin) versus DP(Docetaxel+Cisplatin), TC(Paclitaxel+Carboplatin) as adjuvant chemotherrapy in patients with high risk group of endometrial carcinoma
- patients with high risk group of endometrial carcinoma which is removed surgically
- Japanese Gynecologic Oncology Group
- 2006-11-15